SureTrader
Home > Boards > US Listed > Biotechs > Pluristem Therapeutics, Inc. (PSTI)

IMO..They Should Have Already Dosed The First Couple

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
FDApproved Member Profile
Member Level 
Followed By 2
Posts 1,620
Boards Moderated 0
Alias Born 03/11/17
160x600 placeholder
Pluristem Issues Letter to Shareholders GlobeNewswire Inc. - 2/7/2018 7:44:38 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 2/6/2018 4:22:26 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/6/2018 4:08:38 PM
Pluristem’s PLX Cells Significantly Inhibit Cancer Cell Growth in Newly Published Study GlobeNewswire Inc. - 1/12/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/9/2018 4:04:55 PM
FDA Clears Pluristem’s Expanded Access Program to Initiate Treatments of Critical Limb Ischemia Outside of Ongoing Phase II... GlobeNewswire Inc. - 1/9/2018 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/14/2017 5:18:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/14/2017 5:16:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/14/2017 5:13:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/14/2017 5:11:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/14/2017 5:09:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/14/2017 5:07:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/14/2017 5:04:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/14/2017 5:02:40 PM
Pluristem Granted Manufacturer Authorization and Good Manufacturing Practice (GMP) Certification by Israel’s Ministry of He... GlobeNewswire Inc. - 12/12/2017 5:30:00 AM
Pluristem to Present Data on PLX-R18 in Treatment of Acute Radiation Syndrome at American Society of Hematology’s Annual Me... GlobeNewswire Inc. - 12/7/2017 5:08:17 AM
Peer-Reviewed Article Published on Pluristem’s PLX-PAD Cells’ Mechanism of Action to Restore Blood Flow in Ischemic Tissu... GlobeNewswire Inc. - 11/29/2017 7:00:00 AM
Pluristem Granted Key U.S. Patent for Skeletal Muscle Regeneration - a Meaningful Asset Ahead of Upcoming Phase III Femoral N... GlobeNewswire Inc. - 11/22/2017 7:00:00 AM
Pluristem Reports First Quarter Fiscal 2018 Corporate and Financial Highlights GlobeNewswire Inc. - 11/14/2017 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/7/2017 4:09:24 PM
Pluristem Enters into Agreement with Tel Aviv Sourasky Medical Center to Conduct Phase I/II Trial in Steroid-Refractory Chron... GlobeNewswire Inc. - 11/6/2017 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/31/2017 6:06:01 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/30/2017 4:39:46 PM
Pluristem Announces Pricing of Public Offering of Common Stock on the Tel Aviv Stock Exchange GlobeNewswire Inc. - 10/30/2017 2:45:00 PM
Greenbank Cap, Inc. (OTC Pink: GRNBF) Closes Private Placement as Shares Climb InvestorsHub NewsWire - 10/30/2017 7:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist